Alessandro Natoni (A Natoni)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Oxidative Stress

Multiple Myeloma

Mesenchymal Stem Cells

Top Venues

National University of Ireland Galway

University of Surrey (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National University of Ireland Galway

Ireland

Senior Researcher :: School of Medicine

National University of Ireland Galway

Ireland

Senior Researcher :: Clinical Research Facility

National University of Ireland Galway

Ireland

Postdoctoral Researcher :: National Centre for Biomedical Engineering Science

National University of Ireland Galway

Ireland

Postdoctoral Researcher :: Biochemistry

Medical Research Council, University of Leicester

United Kingdom

Postdoctoral Researcher :: Toxicology Unit

Education History

University of Surrey - Sep 15 2006

United Kingdom

PHD :: School of Medicine

Publications

Marina Cerreto, Robin Foà, Alessandro Natoni
The Role of the Microenvironment and Cell Adhesion Molecules in Chronic Lymphocytic Leukemia. Cancers 15 (21) (2023)
Alessandro Natoni, Marina Cerreto, Maria Stefania De Propris, Maria Teresa Petrucci, Francesca Fazio, Stefania Intoppa, Maria Laura Milani, Lucy Kirkham-McCarthy, Robert Henderson, Dawn Swan, Anna Guarini, Michael O'Dwyer, Robin Foà
Sialofucosylation Enables Platelet Binding to Myeloma Cells via P-Selectin and Suppresses NK Cell-Mediated Cytotoxicity. Cancers 15 (7) (2023)
John Daly, Subhashis Sarkar, Alessandro Natoni, Jessica C Stark, Nicholas M Riley, Carolyn R Bertozzi, Mattias Carlsten, Michael E O'Dwyer
Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell-mediated tumor responses. Blood advances 6 (11) (2022)
Michael E O'Dwyer, R Henderson, S D Naicker, M R Cahill, P Murphy, Vitaliy Mykytiv, J Quinn, C McEllistrim, J Krawczyk, J Walsh, E Lenihan, T Kenny, A Hernando, G Hirakata, I Parker, E Kinsella, G Gannon, Alessandro Natoni, K Lynch, A E Ryan
CyBorD-DARA is potent initial induction for MM and enhances ADCP: initial results of the 16-BCNI-001/CTRIAL-IE 16-02 study. Blood advances 3 (12) (2020)